Many of the in vitro assays for evaluating cardiac liability are based on the prediction of proarrhythmias […]

Traditionally, vanoxerine was developed as a dopamine transporter antagonist for use in the treatment of cocaine addiction, […]

Detection of proarrythmic cardiotoxicity using microelectrode array (MEA) technology and human induced pluripotent stem cell derived cardiomyocytes […]